Genovis AB (publ.) Statistics
Total Valuation
STO:GENO has a market cap or net worth of SEK 1.52 billion. The enterprise value is 1.44 billion.
| Market Cap | 1.52B |
| Enterprise Value | 1.44B |
Important Dates
The next estimated earnings date is Friday, November 7, 2025.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:GENO has 66.06 million shares outstanding.
| Current Share Class | 66.06M |
| Shares Outstanding | 66.06M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 14.60% |
| Owned by Institutions (%) | 15.76% |
| Float | 56.42M |
Valuation Ratios
The trailing PE ratio is 55.98 and the forward PE ratio is 50.85. STO:GENO's PEG ratio is 1.36.
| PE Ratio | 55.98 |
| Forward PE | 50.85 |
| PS Ratio | 12.36 |
| PB Ratio | 6.38 |
| P/TBV Ratio | 6.87 |
| P/FCF Ratio | 64.38 |
| P/OCF Ratio | 61.97 |
| PEG Ratio | 1.36 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 39.44, with an EV/FCF ratio of 60.69.
| EV / Earnings | 53.25 |
| EV / Sales | 11.65 |
| EV / EBITDA | 39.44 |
| EV / EBIT | 54.49 |
| EV / FCF | 60.69 |
Financial Position
The company has a current ratio of 12.69, with a Debt / Equity ratio of 0.34.
| Current Ratio | 12.69 |
| Quick Ratio | 10.17 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 2.26 |
| Debt / FCF | 3.45 |
| Interest Coverage | 6.13 |
Financial Efficiency
Return on equity (ROE) is 12.08% and return on invested capital (ROIC) is 5.37%.
| Return on Equity (ROE) | 12.08% |
| Return on Assets (ROA) | 5.10% |
| Return on Invested Capital (ROIC) | 5.37% |
| Return on Capital Employed (ROCE) | 8.19% |
| Revenue Per Employee | 3.62M |
| Profits Per Employee | 792,853 |
| Employee Count | 32 |
| Asset Turnover | 0.39 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, STO:GENO has paid 10.52 million in taxes.
| Income Tax | 10.52M |
| Effective Tax Rate | 28.06% |
Stock Price Statistics
The stock price has increased by +4.54% in the last 52 weeks. The beta is 1.87, so STO:GENO's price volatility has been higher than the market average.
| Beta (5Y) | 1.87 |
| 52-Week Price Change | +4.54% |
| 50-Day Moving Average | 23.17 |
| 200-Day Moving Average | 24.45 |
| Relative Strength Index (RSI) | 51.52 |
| Average Volume (20 Days) | 77,473 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:GENO had revenue of SEK 123.19 million and earned 26.96 million in profits. Earnings per share was 0.41.
| Revenue | 123.19M |
| Gross Profit | 109.35M |
| Operating Income | 26.00M |
| Pretax Income | 37.47M |
| Net Income | 26.96M |
| EBITDA | 29.58M |
| EBIT | 26.00M |
| Earnings Per Share (EPS) | 0.41 |
Balance Sheet
The company has 168.99 million in cash and 81.58 million in debt, giving a net cash position of 87.41 million or 1.32 per share.
| Cash & Cash Equivalents | 168.99M |
| Total Debt | 81.58M |
| Net Cash | 87.41M |
| Net Cash Per Share | 1.32 |
| Equity (Book Value) | 238.82M |
| Book Value Per Share | 3.65 |
| Working Capital | 194.32M |
Cash Flow
In the last 12 months, operating cash flow was 24.57 million and capital expenditures -921,000, giving a free cash flow of 23.65 million.
| Operating Cash Flow | 24.57M |
| Capital Expenditures | -921,000 |
| Free Cash Flow | 23.65M |
| FCF Per Share | 0.36 |
Margins
Gross margin is 88.76%, with operating and profit margins of 21.10% and 21.88%.
| Gross Margin | 88.76% |
| Operating Margin | 21.10% |
| Pretax Margin | 30.42% |
| Profit Margin | 21.88% |
| EBITDA Margin | 24.02% |
| EBIT Margin | 21.10% |
| FCF Margin | 19.20% |
Dividends & Yields
STO:GENO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 1.77% |
| FCF Yield | 1.55% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 4, 2012. It was a reverse split with a ratio of 0.1.
| Last Split Date | Apr 4, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |